Genesis Cancer and Blood Institute and American Oncology Network Welcome Endocrinologist Dr. Daryl Burrows and Nurse Practitioner Natalie Brown, APRN

Rhea-AI Summary

Genesis Cancer and Blood Institute (AONC) announced on Jan 21, 2026 the addition of board-certified endocrinologist Daryl Burrows, MD, and advanced practice nurse Natalie Brown, APRN to its Hot Springs team. The hires expand Genesis to offer onsite endocrinology alongside oncology across 11 Arkansas locations, enabling coordinated endocrine and cancer care at the Genesis Hot Springs—Higdon Ferry clinic.

The staff additions increase local access to diabetes and endocrine services within the community-based cancer practice.

News Market Reaction

-36.60%

1 alert

-36.60% News Effect

On the day this news was published, AONC declined 36.60%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Medical oncologists: 11 physicians Endocrinologists: 1 physician Advanced practice providers: 6 providers +3 more

6 metrics

Medical oncologists 11 physicians Genesis Cancer and Blood Institute staffing

Endocrinologists 1 physician New endocrinology service at Genesis

Advanced practice providers 6 providers Genesis advanced practitioner team size

Clinic locations 11 locations Genesis sites across Arkansas

Nursing experience Nearly 15 years Natalie Brown’s total nursing experience

Endocrinology experience 10 years Natalie Brown’s experience in endocrinology

Market Reality Check

Price: $12.00 Vol: Volume 931 is at 41% of t...

low vol

$12.00 Last Close

Volume Volume 931 is at 41% of the 20-day average 2,285, indicating subdued trading ahead of this expansion news. low

Technical Shares at 11.75 are trading above the 200-day MA of 8.79, despite a -2.08% move over the last 24 hours.

Peers on Argus

Peers in Medical Care Facilities showed mixed moves: declines in WHTCF (-0.34%),...

Peers in Medical Care Facilities showed mixed moves: declines in WHTCF (-0.34%), gains in HWAIF (3.51%), HLYK (32.58%), and NUMIF (11.94%), while ATIP was flat. This divergence suggests AONC’s modest -2.08% move is more stock-specific than sector-driven.

Historical Context

5 past events · Latest: Oct 10 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Oct 10	Research presentations	Positive	-1.5%	Multiple AON abstracts accepted at ASCO Quality Care Symposium 2025.
Oct 07	Physician addition	Positive	+0.3%	New medical oncologist joined partner practice in Maryland locations.
Sep 02	Physician addition	Positive	+2.8%	Genesis partner practice added Dr. Beau Hilton to oncology team.
Aug 12	Growth update	Positive	+2.0%	Reported >$2B revenue with >40% YoY growth and network expansion.
Jul 24	Quality accreditation	Positive	+15.6%	Central Lab CAP reaccreditation underscored laboratory quality standards.

Pattern Detected

Recent news, mainly positive operational and achievement updates, has more often aligned with share price gains, though there was one instance of a negative reaction to constructive research news.

Recent Company History

Over the past six months, American Oncology Network has highlighted steady operational growth and quality milestones. In July 2025, its Central Lab gained CAP reaccreditation, coinciding with a 15.56% price rise. An August update reported annual revenue above $2 billion with over 40% growth and a broader provider network, followed by a 2% gain. Partner-practice expansions in Arkansas and Maryland generally saw small positive reactions. Today’s Genesis endocrinology addition continues this pattern of incremental network and service expansion news.

Market Pulse Summary

The stock dropped -36.6% in the session following this news. A negative reaction despite service exp...

Analysis

The stock dropped -36.6% in the session following this news. A negative reaction despite service expansion fits prior instances where constructive updates, like multiple ASCO abstracts, coincided with a -1.47% move. Market participants have sometimes discounted non-financial milestones, treating them as longer-term rather than immediate catalysts. With the stock already trading above its 200-day MA, some traders could have locked in gains, while others may reassess how quickly new endocrinology capacity across 11 locations can impact overall performance.

Key Terms

endocrinology, endocrinologist, oncology, clinical trials, +1 more

5 terms

endocrinology medical

"expanding the practice’s services to now include endocrinology care for patients"

Endocrinology is the branch of medicine that studies hormones, which are chemicals produced by glands in the body that regulate important functions like growth, energy, and mood. Understanding how hormones work can reveal insights into health conditions and overall well-being. For investors, it highlights areas of medical research and pharmaceutical development that may influence healthcare trends and market opportunities.

endocrinologist medical

"the addition of Board-certified endocrinologist Daryl Burrows, MD"

A medical specialist who diagnoses and treats conditions caused by hormones and the glands that produce them, such as diabetes, thyroid disorders, and reproductive hormone imbalances. For investors, endocrinologists influence how new drugs, devices, or diagnostic tests are used in practice, help design and interpret clinical trials, and shape prescribing patterns—think of them as the specialist mechanics who determine whether a hormone-related treatment will work and be adopted widely.

oncology medical

"alongside their oncology treatment in a single, community-based setting"

Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.

clinical trials medical

"offers comprehensive cancer care, including diagnosis, treatment, clinical trials, survivorship"

Clinical trials are carefully controlled studies that test whether a new drug, device or treatment is safe and effective in people, moving through successive stages that increase the number of participants and the rigor of testing. Investors care because trial outcomes determine whether a product can be approved and sold, shaping a company’s future revenue, valuation and risk profile—think of it as proof-of-concept testing that decides if a prototype becomes a market-ready product.

aprn medical

"Nurse Practitioner Natalie Brown, APRN, expanding the practice’s services"

An APRN is an Advanced Practice Registered Nurse: a highly trained nurse who can perform many of the same clinical duties as a doctor, such as diagnosing conditions, prescribing medications, and managing patient care. For investors, APRNs matter because their number, training and legal authority affect how quickly and cheaply healthcare services can be delivered—like adding skilled workers to a factory floor increases production capacity and lowers costs.

AI-generated analysis. Not financial advice.

Arkansas-based practice expands care with new endocrinology services

HOT SPRINGS, Ark., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Genesis Cancer and Blood Institute (GCBI), a partner practice of American Oncology Network (AON), is pleased to announce the addition of Board-certified endocrinologist Daryl Burrows, MD, and advanced practice registered nurse Natalie Brown, APRN, expanding the practice’s services to now include endocrinology care for patients in the region.

The addition of Burrows and Brown introduces endocrinology services that were not previously available at Genesis Cancer and Blood Institute, allowing patients to receive specialized endocrine care alongside their oncology treatment in a single, community-based setting.

Dr. Burrows joins an experienced physician team that includes Drs. Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, Kristen Sager, Brad Baltz, Jim Chen, Tyler Fugere and Beau Hilton.

He earned his medical degree from the University of Arkansas for Medical Sciences in Little Rock, where he also completed an internal medicine residency and a fellowship in diabetes, endocrinology and metabolism. He is a member of the American Medical Association, the American College of Physicians, the American Association of Clinical Endocrinologists and the Endocrine Society.

“I am excited to join Genesis Cancer and Blood Institute and to help expand the care available to patients through the addition of endocrinology services,” said Dr. Burrows. “Providing comprehensive, patient-centered care close to home is essential, and this new service allows patients to access specialized endocrine treatment within the same trusted community practice.”

Genesis Cancer and Blood Institute also welcomed Natalie Brown, APRN to its advanced practitioner team. She earned a Master of Science in Nursing from the University of Central Arkansas in Conway and has nearly 15 years of nursing experience, including 10 years in endocrinology.

With 11 medical oncologists, one endocrinologist, and six advance practice providers across 11 locations in Arkansas, Genesis Cancer and Blood Institute offers comprehensive cancer care, including diagnosis, treatment, clinical trials, survivorship and patient support. The addition of endocrinology services further enhances the practice’s ability to deliver coordinated, whole-patient care close to home.

“We are pleased to welcome Dr. Burrows and Natalie Brown to Genesis and to introduce endocrinology services for our patients,” said Robert Muldoon, MD, PhD. “Their expertise significantly expands the care we can provide and reflects our commitment to meeting more of our patients’ needs within our community.”

“Expanding access to specialized services like endocrinology is a meaningful step forward for patients,” said Stephen “Fred” Divers, MD, medical oncologist at Genesis and AON’s chief medical officer. “Dr. Burrows and Natalie Brown strengthen Genesis’ care team and support AON’s mission to deliver high-quality, patient-first community care.”

Burrows and Brown are now seeing patients at the Genesis Hot Springs—Higdon Ferry clinic.

For more information about American Oncology Network, visit AONcology.com. To learn more about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Genesis Cancer and Blood Institute
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute (GCBI) is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. Brad Baltz, Dr. Jim Chen, Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, Dr. Tyler Fugere, Dr. Beau Hilton. The practice also includes Endocrinologist, Dr. Daryl Burrows. Learn more at genesiscancerblood.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ea0319a1-b381-4516-abfb-05e479163ca3

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

FAQ

What endocrinology services did Genesis Cancer and Blood Institute (AONC) add on January 21, 2026?

Genesis added onsite endocrinology care with Daryl Burrows, MD and Natalie Brown, APRN, enabling endocrine care alongside oncology treatment.

Where will Dr. Daryl Burrows and Natalie Brown see patients for Genesis (AONC)?

They are seeing patients at the Genesis Hot Springs—Higdon Ferry clinic in Hot Springs, Arkansas.

What are Dr. Daryl Burrows' qualifications listed by Genesis (AONC)?

Dr. Burrows is board-certified, trained at the University of Arkansas for Medical Sciences, and completed a fellowship in diabetes, endocrinology, and metabolism.

How does the endocrinology addition affect patient care at Genesis (AONC)?

The addition allows patients to receive specialized endocrine care coordinated with oncology services within the same community practice.

How many providers and locations does Genesis Cancer and Blood Institute (AONC) operate after the hires?

Genesis reported 11 medical oncologists, one endocrinologist, six advanced practice providers across 11 Arkansas locations.

How can patients get more information or schedule endocrinology visits at Genesis (AONC)?

Patients can contact the Genesis Hot Springs—Higdon Ferry clinic or visit genesiscancerblood.com for clinic and scheduling information.